| Increased gender variance in autism spectrum disorders and attention deficit hyperactivity disorder JF Strang, L Kenworthy, A Dominska, J Sokoloff, LE Kenealy, M Berl, ... Archives of sexual behavior 43, 1525-1533, 2014 | 306 | 2014 |
| Consensus paper on post-operative pediatric cerebellar mutism syndrome: the Iceland Delphi results T Gudrunardottir, AT Morgan, AL Lux, DA Walker, KS Walsh, EM Wells, ... Child's Nervous System 32, 1195-1203, 2016 | 178 | 2016 |
| The cerebellar mutism syndrome and its relation to cerebellar cognitive function and the cerebellar cognitive affective disorder EM Wells, KS Walsh, ZP Khademian, RF Keating, RJ Packer Developmental disabilities research reviews 14 (3), 221-228, 2008 | 147 | 2008 |
| Postoperative cerebellar mutism syndrome following treatment of medulloblastoma: neuroradiographic features and origin EM Wells, ZP Khademian, KS Walsh, G Vezina, R Sposto, RF Keating, ... Journal of Neurosurgery: Pediatrics 5 (4), 329-334, 2010 | 135 | 2010 |
| Executive functions and social skills in survivors of pediatric brain tumor KR Wolfe, KS Walsh, NC Reynolds, F Mitchell, AT Reddy, I Paltin, ... Child Neuropsychology 19 (4), 370-384, 2013 | 127 | 2013 |
| Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1 KS Walsh, JI Velez, PG Kardel, DM Imas, M Muenke, RJ Packer, ... Developmental Medicine & Child Neurology 55 (2), 131-138, 2013 | 125 | 2013 |
| Intellectual and academic outcome following two chemotherapy regimens and radiotherapy for average‐risk medulloblastoma: COG A9961 MD Ris, K Walsh, D Wallace, FD Armstrong, E Holmes, A Gajjar, T Zhou, ... Pediatric blood & cancer 60 (8), 1350-1357, 2013 | 122 | 2013 |
| Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I study MT Acosta, PG Kardel, KS Walsh, KN Rosenbaum, GA Gioia, RJ Packer Pediatric neurology 45 (4), 241-245, 2011 | 116 | 2011 |
| Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1 JM Payne, B Barton, NJ Ullrich, A Cantor, SJC Hearps, G Cutter, T Rosser, ... Neurology 87 (24), 2575-2584, 2016 | 95 | 2016 |
| Intellectual outcome in molecular subgroups of medulloblastoma I Moxon-Emre, MD Taylor, E Bouffet, K Hardy, CJ Campen, D Malkin, ... Journal of Clinical Oncology 34 (34), 4161-4170, 2016 | 93 | 2016 |
| Efficacy of carboplatin and isotretinoin in children with high-risk medulloblastoma: a randomized clinical trial from the Children’s Oncology Group SES Leary, RJ Packer, Y Li, CA Billups, KS Smith, A Jaju, L Heier, ... JAMA oncology 7 (9), 1313-1321, 2021 | 91 | 2021 |
| Differential effects of lead exposure on components of verbal memory ML Bleecker, DP Ford, KN Lindgren, VM Hoese, KS Walsh, CG Vaughan Occupational and environmental medicine 62 (3), 181-187, 2005 | 68 | 2005 |
| Standard of care for neuropsychological monitoring in pediatric neuro‐oncology: lessons from the Children's Oncology Group (COG) KS Walsh, RB Noll, RD Annett, SK Patel, AF Patenaude, L Embry Pediatric blood & cancer 63 (2), 191-195, 2016 | 61 | 2016 |
| Achieving consensus for clinical trials: the REiNS International Collaboration SR Plotkin, JO Blakeley, E Dombi, MJ Fisher, CO Hanemann, KS Walsh, ... Neurology 81 (21_supplement_1), S1-S5, 2013 | 56 | 2013 |
| Differences in parent and teacher rating of everyday executive function in pediatric brain tumor survivors GC Wochos, CH Semerjian, KS Walsh The Clinical Neuropsychologist 28 (8), 1243-1257, 2014 | 53 | 2014 |
| Systematic review: A prevention-based model of neuropsychological assessment for children with medical illness KK Hardy, K Olson, SM Cox, T Kennedy, KS Walsh Journal of Pediatric Psychology 42 (8), 815-822, 2017 | 49 | 2017 |
| Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials PL Wolters, S Martin, VL Merker, JH Tonsgard, SE Solomon, A Baldwin, ... Neurology 87 (7_Supplement_1), S4-S12, 2016 | 49 | 2016 |
| MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus PMK De Blank, AM Gross, S Akshintala, JO Blakeley, G Bollag, A Cannon, ... Neuro-oncology 24 (11), 1845-1856, 2022 | 48 | 2022 |
| Executive functioning profiles from the BRIEF across pediatric medical disorders: Age and diagnosis factors LS Krivitzky, KS Walsh, EL Fisher, MM Berl Child Neuropsychology 22 (7), 870-888, 2016 | 48 | 2016 |
| Everyday executive function in standard-risk acute lymphoblastic leukemia survivors KS Walsh, I Paltin, GA Gioia, P Isquith, NS Kadan-Lottick, JP Neglia, ... Child Neuropsychology 21 (1), 78-89, 2015 | 45 | 2015 |
